Combine and Conquer: With Type 2 Diabetes Polypharmacy Is Essential Not Only to Achieve Glycemic Control but Also to Treat the Comorbidities and Stabilize or Slow the Advancement of Diabetic Nephropathy
The concept of polypharmacy in the type 2 diabetic patient is both historic and redundant. A combination of three or more medications usually at doses which are less than those utilized for monotherapy is efficacious not only in the therapy of hyperglycemia but also in the therapy of the comorbiditi...
Saved in:
Main Author: | David S. H. Bell |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2022/7787732 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polypharmacy in Patients with Type 2 Diabetes and Arterial Hypertension Treated in a Provincial Hospital
by: José Ander Asenjo Alarcón
Published: (2022-11-01) -
Not Only Glycaemic But Also Other Metabolic Factors Affect T Regulatory Cell Counts and Proinflammatory Cytokine Levels in Women with Type 1 Diabetes
by: Katerina Stechova, et al.
Published: (2017-01-01) -
Nitrones: not only extraordinary spin traps, but also good nitric oxide sources in vivo
by: Croitoru Mircea Dumitru, et al.
Published: (2015-12-01) -
Inflammation in Diabetic Nephropathy
by: Andy K. H. Lim, et al.
Published: (2012-01-01) -
Prescription pattern, glycemic control status, and predictors of poor glycemic control among diabetic patients with comorbid chronic kidney disease in Ethiopia: a facility-based cross-sectional study
by: Oumer Sada Muhammed, et al.
Published: (2025-02-01)